|
Age (years)
|
60 (45–73)
|
56 (46–71)
|
0.412
|
|
Male sex
|
94 (41)
|
7 (35)
|
0.597
|
|
Urologic history
|
|
Indwelling urinary catheter
|
7 (3)
|
0
|
0.428
|
|
Urinary tract disordera
|
71 (31)
|
4 (20)
|
0.304
|
|
Recurrent UTIb
|
50 (22)
|
7 (35)
|
0.191
|
|
Comorbidity
|
|
Diabetes mellitus
|
32 (14)
|
1 (5)
|
0.256
|
|
Malignancy
|
16 (7)
|
1 (5)
|
0.735
|
|
Heart failure
|
21 (9)
|
0
|
0.157
|
|
Cerebrovascular disease
|
12 (5)
|
1 (5)
|
0.963
|
|
Chronic renal insufficiency
|
8 (3)
|
1 (5)
|
0.729
|
|
COPD
|
27 (11)
|
2 (10)
|
0.899
|
|
Immunocompromised
|
14 (6)
|
1 (5)
|
0.841
|
|
Presentation
|
|
At emergency department
|
160 (70)
|
15 (75)
|
0.630
|
|
Antibiotic pre-treatment
|
71 (31)
|
2 (10)
|
0.048
|
|
Fever duration, hours
|
36 (18–72)
|
48 (24–120)
|
0.279
|
|
Dysuria
|
175/224 (78)
|
13/19 (68)
|
0.332
|
|
Flank pain
|
142/225 (63)
|
17 (85)
|
0.049
|
|
Suprapubic pain
|
116/222 (52)
|
11 (55)
|
0.814
|
|
Perineal pain
|
11/222 (5)
|
0/19 (0)
|
0.321
|
|
Systolic BP, mmHg
|
130 (116–146)
|
130 (115–150)
|
0.753
|
|
Diastolic BP, mmHg
|
74 (63–85)
|
72 (68–83)
|
0.585
|
|
Heart rate, beats/minute
|
93 (80–107)
|
96 (78–110)
|
0.695
|
|
Cultures
|
|
Positive urine culture
|
158 (69)
|
13 (65)
|
0.712
|
|
Escherichia coli
|
133/158 (84)
|
10/13 (77)
|
0.497
|
|
Positive blood culture
|
42/220 (19)
|
3 (15)
|
0.654
|
|
Positive urine and/or blood culture
|
169 (74)
|
14 (70)
|
0.712
|
|
Treatment
|
|
Short antimicrobial treatment (7 days)
|
82 (36)
|
10 (50)
|
0.207
|
|
Days of AB, mean (SD)
|
11 (3.3)
|
11 (3.5)
|
0.252
|
|
Ciprofloxacin
|
208 (91)
|
18 (90)
|
0.902
|
|
Amoxicillin (± clavulanic acid)
|
11 (5)
|
2 (10)
|
0.316
|
|
TMP/SMX
|
5 (2)
|
0
|
0.504
|
|
Otherc
|
5 (2)
|
0
|
0.504
|
|
Initial intravenous dose(s) of AB
|
135 (59)
|
12 (60)
|
0.927
|
|
Randomized
|
155 (68)
|
10 (50)
|
0.109
|
|
Outpatient treatment
|
89 (39)
|
7 (35)
|
0.733
|
